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Immunity in the female sheep reproductive tract
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Moredun Research Institute, Pentlands Science Park, Bush Loan, Edinburgh EH26 0PZ, United Kingdom
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Abstract – Immune surveillance in the female reproductive tract is dependent on the interplay of
many factors that include the expression of pattern recognition receptors on epithelial cells, resident
leukocyte populations and hormones, none of which are uniform. The lower reproductive tract must
accommodate the presence of commensal organisms whereas the upper reproductive tract is sterile.
However, the upper female reproductive tract has its own immunological challenge in that it must
tolerate the presence of a semi-allogeneic fetus if pregnancy is to succeed. So, immune activation
and effector mechanisms to control pathogens may be qualitatively and quantitatively different
along the reproductive tract. Our knowledge of innate and adaptive immunity in the sheep is less
comprehensive than that of human or mouse. Nevertheless, comparative studies suggest that there
are likely to be conserved innate immune sensory mechanisms (e.g. Toll-like receptors) and defence
mechanisms (anti-proteases, defensins) that combine to limit infection in its early stages while
shaping the adaptive response that leads to immunological memory and long-term protection. There
are many pathogens that target the reproductive tract, and in particular the placenta, where
specialised immunoregulatory mechanisms are operational. Among such pathogens are bacteria
belonging to the genera Chlamydia/Chlamydophila that chronically infect the reproductive tracts of
sheep and humans and ultimately cause disease through inflammation and tissue damage. An
understanding of the immunological microenvironment of the reproductive tract is important for the
design of novel control strategies to control chlamydial disease. 
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1. INTRODUCTION
Mucosal sites inhabited by commensal
flora need to be capable of discriminating
between commensals and the pathogenic
organisms they encounter in order to gen-
erate protective immune responses. The
lower female reproductive tract is one such
site, whereas the upper reproductive tract is
normally sterile [66]. These differences in
microbial exposure along the reproductive
tract suggest that the innate defence mech-
anisms required to sense and respond to
micro-organisms are unlikely to be uniform
from vagina to uterus [79]. This is exempli-
fied by the fact that organisms that are harm-
less (or even beneficial) to the host at one
anatomical site can cause disease when
introduced to another. 
The innate immune system performs three
important functions: firstly, it prevents infec-
tion through physical means; secondly, should
infection occur, it produces anti-microbial
compounds designed to limit pathogen mul-
tiplication until the adaptive response has
time to develop; and thirdly, it produces
immunomodulatory molecules that drive
the phenotype of the adaptive immune
response. This combination of defence mech-
anisms is necessary for the host to protect
itself from a wide range of infectious agents.
The most notable infectious diseases of
the reproductive tract of sheep are those that
infect the placenta and cause abortion.
These can be of viral (Border disease virus),
bacterial (Chlamydophila abortus, Salmo-
nella spp., Campylobacter spp., Listeria spp.,
Brucella spp.), rickettsial (Coxiella burnetii)
or protozoal (Toxoplasma gondii) aetiology
[52]. Some of these abortifacient agents are
zoonotic and therefore pose a risk to human
health and are of comparative medical inter-
est. In many cases they cause abortion when
the ewe is infected for the first time during
pregnancy, and although not causing severe
clinical disease in the ewes, are fatal for the
fetus. The stage of gestation at which expo-
sure occurs often affects the outcome of
infection. However, in certain cases, nota-
bly C. abortus, infection can be established
prior to pregnancy and clinically manifest
itself only when ewes abort. There are two
important points to establish at the outset.
The first is that although these pathogens
cause disease in the reproductive tract, their
route of transmission is most commonly
oro-nasal rather than venereal [52]. This
indicates that the extra-uterine immune
response following primary infection is not
sufficient to prevent systemic dissemina-
tion to the placenta. The second is that dis-
ease manifests itself in the placenta and not
at other anatomical sites. This is likely to be
reflective of the specialised immune envi-
ronment of the pregnant uterus necessary to
accommodate the semi-allogeneic fetus
which may not be compatible with the type
of immune response necessary for pathogen
control. 
This review will draw on our current
knowledge of the physiology and immunol-
ogy of the female reproductive tract of
sheep, integrate this with comparative
information from other species and discuss
how the various factors contribute to dis-
ease pathogenesis and reproductive failure.
2. REPRODUCTION IN FEMALE 
SHEEP 
2.1. Anatomy of the reproductive tract
The reproductive tract of the ewe con-
sists of a vestibule leading to the vagina,
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separated from the bipartite uterus by the
cervix, with the uterus linked to the ovaries
by the uterine tubes (Fig. 1). The urethra
joins the reproductive tract at the base of the
vagina and marks the boundary with the
vestibule, making the vestibule common to
both the reproductive and urinary tracts.
The gross anatomical differences between
the lower and upper reproductive tracts are
reflected in the differences in the mucous
membranes that line them. The vagina has
a stratified squamous epithelium whereas
the glandular mucosa that lines the uterus
(the endometrium) has a stratified columnar
epithelium. The endometrium of the sheep
has approximately 90 caruncles. Caruncles
are protruding cup-like structures that act as
sites of attachment for the fetal cotyledons
of the placenta during pregnancy. The
uterus is glandular, with uterine glands dis-
tributed around the endometrium, except in
the caruncles. 
2.2. The ovine placenta
The ovine placenta is synepitheliochor-
ial, meaning that the fetal chorion makes
direct contact with the uterine epithelium
[81]. There is less invasion of the maternal
tissue by fetal cells in this type of placenta
than in the hemochorial placenta of humans
and some rodent species. However, some
ovine fetal trophoblast cells from the coty-
ledonary villi in the placentome do fuse
with maternal cells in the endometrium to
form characteristic binucleate cells. Exchange
of nutrients and waste products between the
dam and fetus occurs in the placentomes,
structures comprised of a cotyledon and a
caruncle. The placentomes contain inter-
digitating villi to increase the surface area
between fetus and ewe (Fig. 2). 
2.3. Reproductive hormones 
Reproduction is an energy-demanding
process, particularly for females. It is there-
fore advantageous for female mammals to
conceive at times that result in their young
being born with the best chance of survival.
The reproductive pattern is dictated by hor-
mones, and the period when females are
sexually receptive is known as oestrus.
Sheep are polyoestrus, which means that
they can have successive oestrus cycles dur-
ing their breeding season. The number of
cycles varies between breeds, ranging from
1–20, and appears to be linked to the climate
to which the breed is adapted, ensuring
lambs are born in the most favourable con-
ditions. The average oestrus cycle in ewes
is around 17 days, with oestrus itself (ovu-
lation) lasting 24–48 h. The levels of vari-
ous hormones vary in the plasma during
Figure 1. Schematic view of the female
sheep reproductive system.
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the cycle. Oestrus is preceded by an increase
in follicle-stimulating hormone, which
decreases as oestrogen levels rise, promot-
ing a surge of luteinising hormone which
then leads to ovulation. Progesterone levels
are at their lowest around ovulation. If the
ovum that is released is fertilised, an embryo
will begin to develop in the uterus. At this
stage it is important for the fertilised ovum
to develop, and also for the ewe to stop pro-
ducing further ova. To this end, the embryo
secretes products that inhibit uterine secre-
tion of prostaglandin F2α (PGF2α). PGF2α
is a product of the non-pregnant uterus that
causes leutolysis and regression of the cor-
pus luteum, a structure in the ovary that pro-
duces high levels of progesterone. Proges-
terone inhibits further oestrus cycles and
promotes attachment and development of
the embryo, thereby allowing pregnancy to
progress. This process is known as maternal
recognition of pregnancy. In some species
the corpus luteum is the primary source of
progesterone throughout pregnancy. How-
ever, in the ewe after day 50 of gestation the
placenta itself secretes sufficient progester-
one to maintain pregnancy (the gestation
period of sheep is around 147 days). Plasma
levels of progesterone increase markedly in
ewes between days 90 and 125 gestation,
then drop sharply before parturition. Levels
of oestrogen increase from around day 120
and show a sharp rise 24 h prior to parturi-
tion. Levels of prostaglandin E2 (PGE2) are
also greatly elevated in the latter stages of
pregnancy and around parturition [28, 81]. 
Some of these hormones are known to
directly influence immune function, nota-
bly oestrogen, progesterone and PGE2.
Fluctuations in hormone levels during the
reproductive cycle and pregnancy are there-
fore of considerable interest when consid-
ering host immune control of infectious dis-
ease in the reproductive tract [4]. The
effects of hormones on immune function
will be discussed in detail in Section 4. 
3. INNATE IMMUNITY IN THE 
REPRODUCTIVE TRACT
3.1. Physical barriers to infection
Physical barriers form the first line of
host defence at mucosal surfaces. For exam-
ple, tight epithelial junctions and mucosal
secretions are important factors in prevent-
ing microbial access to tissues. Vaginal
commensals such as Lactobacillus spp. pro-
duce lactic acid and hydrogen peroxide to
create a low (< 5) pH environment. This
helps to protect the lower reproductive
tract from pathogenic micro-organisms and
thereby reduces the possibility of infection
reaching the upper reproductive tract [66].
Nevertheless, most pathogens that enter the
body do so via mucosal surfaces, so the host
needs to be able to identify and respond rap-
idly and appropriately to limit the spread of
infection. 
Figure 2. (a) The cotyledonary placenta of sheep at parturition. (b) The placentome structure at it
exists in utero. Fetal cotyledons attach to caruncles on the maternal uterine epithelium to form the
placentomes. The villi interdigitate to facilitate exchange of nutrients and waste materials.
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3.2. Pathogen recognition 
It had long been considered that the
innate response was non-specific whereas
specificity for host immunity was conferred
by the adaptive response, with lymphocytes,
and in particular CD4+ T cells, dictating
how the host responded. This paradigm has
shifted somewhat in recent years with the
discovery of pattern recognition receptors
(PRR). PRR (e.g. the Toll-like receptors;
TLR) respond to generic pathogen-associ-
ated molecular patterns (PAMP) such as
lipopolysaccharide (LPS), flagellin, unmeth-
ylated oligodeoxynucleotides (ODN), dou-
ble-stranded RNA and heat shock proteins
(hsp). Ligation of PRR by PAMP elicits dis-
tinct cytokine profiles by responding cells
which confers a previously unrecognised
level of specificity to the innate response
[37, 48]. These recognition pathways are
prophylactically important since they can
potentially be exploited by carefully-designed
delivery strategies to drive the adaptive
response to candidate vaccine antigens in an
appropriate direction. 
TLR are transmembrane proteins that
exhibit specificity for distinct PAMP. The
intracellular signalling domain of TLR
resembles that of the interleukin-1 receptor.
Binding of the specific PAMP to the TLR
initiates a cascade which leads to activation
and translocation of nuclear transcription
factors that result in distinct patterns of
expression of immune-related genes [75]. 
Eleven TLR are expressed in humans,
between them detecting a wide range of
products from bacteria, viruses and proto-
zoa [37, 48]. TLR have been cloned in a
wide variety of experimental and domestic
species, including mice, chickens, pigs,
dogs and cats. To date no TLR homologues
have been cloned in the sheep, but TLR
have been cloned in cattle [78]. Immuno-
histochemical analyses have revealed the
expression of TLR 1, 2, 3, 5 and 6 through-
out the human reproductive tract, whilst
TLR 4 is only found in the upper tract [24].
This supports a previous report of decreased
expression of mRNA encoding TLR4, but
not TLR2, in the lower reproductive tract
compared to the upper tract [64]. TLR4, in
conjunction with CD14 and MD-2, is
thought to be the principal pathway through
which cells recognise bacterial LPS [58].
This has implications for mucosal sites that
harbour commensal Gram-negative micro-
organisms. Tolerance of commensal micro-
flora by the gut mucosal epithelium can be
achieved by a down-regulation of TLR4
and MD-2 expression [2]. It has also been
proposed that the failure of epithelial cells
to express CD14 is to prevent the host
mounting unnecessary responses to com-
mensal Gram-negative bacteria [22]. Inter-
estingly, human uterine epithelial cells
express the mRNA encoding TLR 1–9 and
respond to TLR agonists (with the excep-
tion of LPS) by releasing pro-inflammatory
cytokines [68, 69]. Human uterine epithe-
lial cells also require soluble CD14 to
respond effectively to LPS, even though the
uterus is normally sterile [34]. 
Choriocarcinoma cell lines derived from
human placenta express TLR 1–10 [47].
TLR2 and TLR4 protein expression in
human placenta is strongest on the tropho-
blasts that cover the peripheral chorionic
villi and which constitute the immediate
barrier between mother and fetus [35]. Tro-
phoblasts can produce cytokines following
TLR4 ligation, but undergo apoptosis fol-
lowing TLR2 ligation [1]. 
Collectively, these studies indicate that
there is the potential for microbial detection
in both the lower and upper reproductive
tracts, but with some qualitative differences.
This suggests that micro-organisms can elicit
different responses along the reproductive
tract and may even influence fetal survival
during gestation. 
3.3. Defensins
Epithelial cells of the female reproduc-
tive tract not only have the potential to rec-
ognise pathogens, but they are also capable
of responding to infection by producing
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antimicrobial compounds, chemokines and
cytokines. Among the antimicrobial com-
pounds are the defensins, a highly-conserved
group of cationic peptides that exhibit a
broad spectrum of activity against bacteria,
fungi and viruses [29]. The two main defensin
sub-families are the α- and β-defensins. The
α-defensins are produced mainly by neu-
trophils and Paneth cells whilst the
β-defensins are produced by epithelial cells
and keratinocytes [29, 33]. Six human
β-defensins have so far been identified. Of
these, human β-defensins (HBD)-1-4 are
expressed in the endometrium, although
their expression can be regulated by differ-
ent stimuli [44]. For example, expression
of HBD-2 and HBD-3 can be up-regulated
in endometrial cells by pro-inflammatory
cytokines such as IL-1β plus TNF-α or by
IFN-γ [42, 45]. HBD-1 is constitutively
expressed by epithelial cells at several
mucosal sites whereas HBD-2 is inducible
by LPS [5, 77]. 
In addition to their antimicrobial roles,
β-defensins also have immunomodulatory
properties. HBD-2 binds the chemokine
receptor CCR6, thereby acting as a chem-
oattractant for immature dendritic cells
and memory T cells [82], whereas murine
β-defensin-2 binds TLR-4 on dendritic cells
and can initiate inflammatory host immune
responses [7].
Two β-defensins have been identified in
the ovine gastrointestinal tract and these
have been termed SBD-1 and -2 [38]. There
are no reports of α-defensins in sheep. Sim-
ilar to the expression pattern of HBD-1,
SBD-1 is constitutively expressed in epi-
thelial cells throughout the gastrointestinal
tract. SBD-2 is expressed in the gut, lung
and uterus [3, 56]. It is not yet possible to
say if and how SBD-1 or -2 contribute to
innate immune defence in the reproductive
tract of sheep or how their expression is reg-
ulated. However, it is known that SBD
expression in ovine lung is modulated by
pathogens. Mannheimia haemolytica down-
regulates SBD-1 and -2 expression [3],
whereas parainfluenza virus up-regulates
SBD-1 expression [30]. This indicates that
reproductive pathogens may have a similar
modulatory effect to promote their survival.
3.4. Anti-proteases 
Cells within human female reproductive
tract produce the anti-protease molecules
elafin and secretory leukocyte protease
inhibitor (SLPI). Both elafin and SLPI neu-
tralise the elastases that are produced by
infiltrating neutrophils during infection and
are thought to be important in regulating
tissue damage as a result of the inflamma-
tory process. In addition, both molecules
exhibit antimicrobial properties and there-
fore contribute to innate host defence. Ovine
orthologues of SLPI and elafin have been
recently cloned. Both molecules are induced
by LPS challenge in the ovine lung and pos-
sess anti-elastase properties [8, 9]. The
direct anti-microbial properties of ovine
SLPI and elafin remain to be established
and expression of ovine SLPI and elafin
within the ovine female reproductive tract
not been determined. However given the
similarity in the expression patterns at other
mucosal sites compared with other species
it would be highly surprising if SLPI or
elafin were not components of the innate
immune strategy of the ovine female repro-
ductive tract. 
SLPI is expressed by cell lines derived
from various sections of the human female
reproductive tract, including the vagina,
cervix, endometrium and decidua, as well
as trophoblasts in the placenta [25, 41].
Elafin is expressed by epithelial cells in the
human vagina and endometrium [43, 63].
Like defensins, expression of mRNA encod-
ing for elafin in primary human endometrial
cells is up-regulated by IL-1β plus TNF-α
[43]. However, the same cytokine stimulus
does not increase mRNA encoding SLPI in
primary human endometrial cells, but does
in endometrial cell lines, highlighting the
importance of careful data interpretation
from in vitro observations [42]. 
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3.5. Other innate antimicrobial defence 
mechanisms 
There are other molecules expressed in
the human female reproductive tract that
have antimicrobial activity and also chem-
otactic activity. Such molecules are likely
to be important bridges between innate and
adaptive immune responses and will be of
interest to define in sheep. For example, the
stratified squamous epithelium of the human
vagina produces surfactant protein A (SP-A),
a collagenous lectin formally thought to be
restricted to lung [79]. SP-A is antimicro-
bial, influences cytokine production and is
involved in chemotaxis. CCL20/macro-
phage inflammatory protein (MIP) 3α is a
chemokine produced by human uterine epi-
thelial cells. It is a ligand of CCR6, the
receptor that also binds human β-defensins,
suggesting homology between CCL20 and
the human β-defensins. Consistent with this,
CCL20 exhibits anti-microbial activity [36]. 
4. FEMALE REPRODUCTIVE 
HORMONES AND INNATE 
IMMUNITY 
Hormones play a very important role in
regulating host immunity in the genital tract,
distinguishing this from other mucosal sites
[39]. There is a vast body of literature on the
influence of female hormones on cell pop-
ulations, antigen presentation and cell func-
tion in the reproductive tracts of humans
and mice (see [80] for review), but not in
sheep. Hormone levels fluctuate during the
reproductive cycle, influencing immune
surveillance and disease susceptibility. For
example, HBD expression in the endometrium
is differentially regulated by the menstrual
cycle and by the oral contraceptive pill [26,
44]. Expression of SLPI also fluctuates dur-
ing the menstrual cycle, increasing in
human epithelial cells in response to pro-
gesterone or in rat uterus in response to oes-
trogen [14, 46, 79]. Although hormones
dominate the reproductive tract environ-
ment, not all products of epithelial cells are
modulated by hormones, so there is a selec-
tive effect. For example, unlike many other
products of epithelial cells of the female
reproductive tract, expression of SP-A is
not influenced by hormones and remains
constitutive [51]. Studies on hormonal
influences in the reproductive tract in sheep
have focussed primarily on pregnancy. This
will be discussed in Section 6. 
5. ADAPTIVE IMMUNITY IN THE 
REPRODUCTIVE TRACT 
Humoral and cellular adaptive immune
effector mechanisms operate in the repro-
ductive tract. Immunoglobulin A (IgA) and
IgG are found in uterine and vaginal secre-
tions [80]. The normal healthy female gen-
ital tract harbours few T cells, but infection
with Chlamydia trachomatis results in
recruitment of CD4+ve and CD8+ve T cells
[39]. The same study also found a unique
population of T cells in the mouse uterus
that appear to perform a regulatory role
rather than a protective role. These cells are
TCRαβ+ve, CD3+ve, CD4-ve, CD8-ve,
inhibit proliferation of splenic T cells and
are extrathymically-derived, since they are
found in nude mice. It is thought that they
represent a highly specialised population of
T cells with a particular function in the
female genital tract, but this remains to be
fully defined [39]. They are not the same as
conventional CD4+veCD25+ve regulatory
T (Treg) cells, key control elements of the
adaptive immune response that suppress
auto-reactive T cells and prevent inflamma-
tion-mediated tissue damage [71]. Some
broad “signature” characteristics of Treg
cells are expression of the transcription fac-
tor FoxP3 and the production of IL-10 and
TGF-β, two cytokines that exert immuno-
suppressive effects [74]. 
6. PREGANCY AND HOST 
IMMUNITY
6.1. Accommodation 
of the semi-allogeneic fetus
It was recognised by Peter Medawar over
fifty years ago that mammalian pregnancy
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was not compatible with the self-nonself
model of immune activation, and that adap-
tations of maternal immunity and/or spe-
cialised immunological characteristics of
the placenta allow survival of the semi-all-
ogeneic fetus [53]. This paradox has still not
been fully resolved, but we do know that the
specialised immunological and physiolog-
ical interactions at the materno-fetal inter-
face are complex. The structure of the pla-
centa is central to successful pregnancy, yet
it is not uniform across eutherian mammals,
reflective of differences in gestation peri-
ods, litter sizes and number of mates (genetic
diversity) between species [6]. Some key
immunological features of mammalian
pregnancy are listed in Table I. Note that
these have been derived principally from
studies in humans and mice. Their existence
in sheep and relative contribution to the suc-
cess of ovine pregnancy remains largely
unknown, and inter-species comparisons
must be drawn with care [6, 18]. 
6.2. Uterine lymphocyte populations
The pregnant sheep uterus has an increased
number of intraepithelial CD8+ve/γδ T cell
receptor (TCR) +ve large granular leuko-
cytes (LGL) compared to the non-pregnant
uterus [54]. These cells are more granular
in the pregnant uterus, suggesting a state of
activation that is reminiscent of the granular
CD56bright NK cells that have been postu-
lated to perform an important role in limit-
ing trophoblast invasion in the human
hemochorial placenta [57]. Supportive of
this hypothesis, ovine uterine CD8+ve/γδ
TCR+ve LGL express perforin, suggesting
a cytolytic function [27]. Both γδ TCR+ve
LGL and NK cells are found in human
decidua [17, 55]. Fluctuations in the number
of uterine LGL may be due, at least in part,
to hormone production. Progesterone and
oestradiol induce a pattern of chemokine
expression in human endometrium that is
consistent with the fluctuating numbers of
Table I. Specialised immunological features at the materno-fetal interface that promote successful
pregnancy. These observations are drawn from several species and it a matter of speculation if they
are operational in sheep.
Immune modulator Effect
Fetal/trophoblast
Lack of expression of classical MHC class I or 
MHC class II molecules
Evade recognition by maternal αβ T cells
Expression of non-classical MHC class I
molecules
Evade lysis by maternal NK cells
Expression of Fas ligand Induce apoptosis of Fas-bearing maternal T cells 
and neutrophils
Expression of IDO Tolerise maternal T cells
Production of IL-10 and TGF-β Down-regulate maternal immune reactivity 
Production of hormones Favour maternal Th2-type immunity 
No ‘Danger’ signal No activation of maternal immunity
Maternal
Uterine NK cells/γδ T cells Control trophoblast invasion
Absent/low expression of IL-2, TNF-α and IFN-γ Minimise inflammatory cell activation, promotion 
of trophoblast survival
Hormone production Bias maternal immunity away from an inflamma-
tory phenotype
Production of GM-CSF, CSF-1 Promote placental development
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uterine NK cells during the menstrual cycle
[70]. The number of γδ TCR+ve intraepi-
thelial LGL in the ovine uterus drops dra-
matically within days of parturition. This
decrease is due to a combination of cell
migration, apoptosis and degranulation,
suggesting that they have completed their
function in the inter-placentomal areas of
the uterine epithelium during pregnancy
[59]. Both progesterone and a uterine serine
proteinase inhibitor have been postulated to
have immunoregulatory roles in the preg-
nant ovine uterus [32, 76]. Inhibition of the
cytolytic activity of ovine endometrial cells
by the uterine serine proteinase inhibitor
may be necessary to protect the mother from
the potentially invasive fetus while allow-
ing sufficient contact for nutrient and waste
exchange [76]. 
An unequivocal description of NK cells
in sheep has remained elusive, so it has been
impossible to ascribe a definitive function
during ovine pregnancy. A monoclonal anti-
body (Mab) produced against a molecule
expressed on cytotoxic cells of fish (NK5C6,
anti-Function Associated Molecule; anti-
FAM) but which reacts with rodent and
human NK cells, has been found to inhibit
the activity of cytotoxic cells derived from
ovine endometrium [76]. However, NK5C6
does not react with ovine peripheral blood
leukocytes (PBL) in flow cytometry or
detect leukocytes in ovine endometrium by
immunocytochemistry. These conflicting
data may be in part due to the isotype of
NK5C6. It is an IgM Mab, an isotype that
is technically more difficult to work with
than IgG Mab. Reagents and probes that
identify NK cell receptors in cattle have
recently been developed which may be
applicable in sheep. Cattle have genes that
encode killer cell immunoglobulin like
receptors (KIR), CD94 (a killer cell lectin-
like receptor) and NKp46 (an activating
receptor expressed exclusively on NK cells
in the human) [72]. A Mab produced against
recombinant bovine NKp46 reacts with
cytotoxic bovine PBL [73]. However, it is
not yet known if this Mab detects uterine
NK cells in cattle, or if it cross-reacts with
ovine PBL. 
6.3. Regulatory T cells
Treg cells can regulate allo-responses
and are of great interest as therapeutic tar-
gets in transplantation medicine. It is there-
fore not surprising that Treg cells have now
become a focus of attention in reproductive
immunology and tolerance of the semi-all-
ogeneic fetus. Expansion of the Treg pop-
ulation has been found in both the uterus and
the maternal periphery during pregnancy.
Mouse models indicate a role for Treg in
preventing maternal rejection of semi-allo-
geneic, but not syngeneic, fetuses [67, 83].
Oestrogen increases both the number of
splenic CD25+ve T cells and FoxP3 expres-
sion within those cells in mice, indicating
that Treg cells are affected by the hormonal
environment [65]. Treg have not yet been
defined in sheep. 
7. CHLAMYDIAL INFECTION 
IN THE REPRODUCTIVE TRACT
Chlamydia/Chlamydophila are obligate
intracellular Gram-negative bacteria that
cause a variety of diseases in many hosts
[50]. With regard to infection of the repro-
ductive tract, two of these organisms stand
out. Chlamydia trachomatis is the most
common diagnosed sexually-transmitted
infectious agent in humans in the UK1 while
Chlamydophila abortus is by far the single
most common cause of infectious ovine
abortion reported annually in the UK2. Both
organisms can cause inapparent primary
infections that then result in reproductive
failure as they persist. Chronic C. trachom-
atis infection prevents fertilization or implan-
tation as a result of inflammation and
1
 Health Protection Agency, Chlamydia (Chlamy-
dia trachomatis) [on line] (2005) http://
www.hpa.org.uk/infections/topics_az/hiv_and_sti/
sti-chlamydia/chlamydia.htm.
2
 Veterinary Laboratories Agency, [on line] (2005)
http://www.defra.gov.uk/corporate/vla/science/
science-vida03b.htm.
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scarring of the upper reproductive tract
whereas C. abortus causes abortion associ-
ated with inflammation and tissue destruc-
tion of the placenta. C. abortus persists in the
non-pregnant ewe (at a site as yet unidenti-
fied), but then can be found in the placenta
from around day 90 gestation of the preg-
nancy subsequent to infection. Abortion
occurs around day 125–135 gestation, which
is typically 2–3 weeks before the end of the
normal gestation period of 147 days [12].
The susceptibility of epithelial cells in
the female reproductive tract to C. tracho-
matis is not uniform during the reproductive
cycle. Pig cervical epithelial cells isolated
in the early (oestrogen-dominant) phase of
the cycle are around ten times more suscep-
tible than cells isolated later in the cycle
(progesterone-dominant) [31]. It has been
proposed that C. trachomatis may exploit
the oestrogen receptor to facilitate entry
into host cells [16]. It is not known if
C. abortus utilizes this mechanism in sheep,
but if so, it would help to explain the obser-
vations of increased shedding of C. abortus
during estrus in infected ewes [62]. 
7.1. Host immunity
For both C. abortus and C. trachomatis,
protective host immunity is dependent on a
Th1-type response dominated by IFN-γ pro-
duction. IFN-γ induces intracellular expres-
sion of indoleamine 2,3-dioxygenase (IDO),
a tryptophan-degrading enzyme. Since
C. abortus and C. trachomatis are auxo-
trophic for tryptophan, they cannot multiply
if IDO is activated [10, 21]. It is worth noting
that the hormonal changes associated with
pregnancy and oestrus do not favour the pro-
duction of IFN-γ. This may allow a persistent
or latent extra-uterine chlamydial infection
to recrudesce and invade the placenta [18].
Sheep develop clinically protective immu-
nity to C. abortus after abortion, such that
repeat abortions are rare [20]. This does not
necessarily reflect induction of sterile immu-
nity in the ewe, since infectious organisms
can be recovered from the vagina during estrus
of sheep that have previously aborted [62].
7.2. Route of infection
As previously mentioned, although
C. abortus causes reproductive disease, the
common route of transmission to suscepti-
ble sheep is oro-nasal, the most likely source
of infection being contaminated placentas
of aborting ewes. Nevertheless, sexual trans-
mission cannot be ruled out. Experimental
vaginal inoculation of ewes prior to breed-
ing can cause abortion whereas subcutane-
ous inoculation does not [61]. However,
infection by either the vaginal or subcuta-
neous route in ewes that are pregnant results
in abortion. Moreover, infection by the sub-
cutaneous route prior to breeding actually
protects against abortion in sheep re-chal-
lenged during pregnancy. These observa-
tions indicate that C. abortus infection of
non-pregnant sheep by a mucosal route
induces a qualitatively different response to
that elicited by subcutaneous infection, the
former allowing the establishment of a per-
sistent infection that manifests itself by caus-
ing abortion in a subsequent pregnancy. 
Chlamydiae can activate early innate
immune responses via PAMP ligation of
PRR to influence disease progression. Ovi-
duct pathology is significantly reduced in
TLR2 knockout (but not TLR4 knockout)
mice infected with C. trachomatis. Moreo-
ver, ligation of TLR4 by whole organisms
appears to have an anti-inflammatory effect
[15]. Chlamydial hsp60 can activate cells
through ligation of TLR4 [11], whereas
C. trachomatis LPS is recognised by TLR2
[23]. Activation via TLR2 but not TLR4 in
human trophoblasts can lead to apoptosis in
vitro [1]. If this occurs during placental
infection with C. abortus, the resulting dam-
age to the placenta could compromise the
pregnancy. PRR expression at the site of
primary infection can therefore influence
how the host responds, which may be the
case in sheep infected by C. abortus by dif-
ferent routes. This question can be addressed
when reagents become available to investi-
gate PRR expression in the reproductive
tract of sheep. 
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7.3.  Mechanism of abortion
The exact cause of abortion as a result of
C. abortus infection is not known. Our cur-
rent knowledge points to a combination
of factors that include damage to the pla-
centomes, destruction of the chorionic
epithelium, hormone imbalance, maternal
leukocyte infiltration of the uterus, fetal
mononuclear cell placental infiltration, and
placental thrombosis as a consequence of
placental expression of inflammatory medi-
ators such as TNF-α that are incompatible
with successful pregnancy [13, 18, 60].
There is a notable paradox regarding
chlamydial abortion. IDO is constitutively
expressed in both human and mouse tro-
phoblast (see Tab. I), despite both species
being susceptible to abortion as a result of
natural (human) or experimental (mouse)
placental infection with C. abortus [22, 40].
Since the function of IDO in the placenta is
to degrade tryptophan and tolerise maternal
T cells to paternal allo-antigens, one would
expect this to be an inhospitable site for C.
abortus, but it clearly is not. However, IDO
expression in trophoblast varies dependent
on the stage of pregnancy [19]. This could
explain why C. abortus can target the pla-
centa at particular stages of pregnancy and
raises important questions about immune
regulation at the materno-fetal interface in
sheep. As yet, ovine IDO has not been
cloned so it is not known what role, if any,
it plays in the syneptheliochorial placenta of
sheep or in regulation of T cell immunity in
general in ruminants. Such information will
be very valuable in building a more com-
plete picture of the pathogenesis of ovine
chlamydial abortion and inform on the
design of new control strategies.
8. CONCLUSIONS AND FUTURE 
PROSPECTS
Infectious diseases of the reproductive
tract in sheep, particularly those that cause
abortion, impact on animal health, welfare,
production and the economy worldwide.
However, the fact that many of these abor-
tifacient agents reach the uterus and pla-
centa systemically following primary infec-
tion at a remote mucosal site rather than by
venereal transmission suggests that control
by non-mucosal vaccine delivery should be
a viable prophylactic option. This is indeed
the case. To take C. abortus as an example,
parenteral administration of live-attenuated
or whole-killed organisms protect sheep
against abortion [49]. Nevertheless, ovine
chlamydial abortion remains a problem.
The reasons for this are complex, and are
not just related to immune responses, but
involve facets of animal management sys-
tems and diagnostic surveillance that have
resulted in poor uptake of the available vac-
cines. Sub-unit vaccines and alternative
delivery systems could circumvent these
problems. 
One would predict that a combination of
mucosal and systemic immunity would pro-
vide the best protection against C. abortus
infection in sheep. This would ideally
involve antigen delivery via a mucosal sur-
face such as the reproductive tract. By selec-
tively targeting components of the innate
immune system, the induction of an appro-
priate adaptive memory response could be
achieved. A greater understanding of the
innate and adaptive elements operational in
the female reproductive tract in sheep is
required for such a rational approach to vac-
cine design. We can draw on existing com-
parative knowledge of human and mouse
reproductive tract immunology to prioritise
research into those molecules that are likely
to play a role. Conversely, evaluation of
chlamydial vaccines in sheep will inform on
suitable strategies for human chlamydial
vaccines, of which there are currently none. 
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